Impact of Baseline Renal Function on the Efficacy and Safety of Aliskiren Added to Losartan in Patients With Type 2 Diabetes and Nephropathy

OBJECTIVE: Proteinuric diabetic patients with reduced glomerular filtration rate (GFR) are at high risk of renal and cardiovascular disease progression and treatment-related adverse events. This post hoc analysis assessed the efficacy and safety of aliskiren added to the maximal recommended dose of...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Persson, Frederik, Lewis, Julia B., Lewis, Edmund J., Rossing, Peter, Hollenberg, Norman K., Parving, Hans-Henrik
Format: Artigo
Jezik:Inglês
Izdano: American Diabetes Association 2010
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2963484/
https://ncbi.nlm.nih.gov/pubmed/20693353
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc10-0833
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items